The role of the oxidative state of glutathione and glutathione-related enzymes in anemia of hemodialysis patients

Clinical Biochemistry

Volumn 29, Issue 6, 1996, Pages 567-572

  Paşaoǧlu, Hatice ^a,b   Muhtaroǧlu, Sabahattin ^a   Güneş, Mehmet ^a   Utaş, Cengiz ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

Author keywords

glucose 6 phosphate dehydrogenase; glutathione; glutathione peroxidase; glutathione reductase; hemodialysis

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE;

ADULT; ANALYTIC METHOD; ANEMIA; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; FEMALE; GLUTATHIONE METABOLISM; HEMODIALYSIS; HEMOLYSIS; HUMAN; MALE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; UREMIA;

EID: 0030561531     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(96)00097-5     Document Type: Article

References (36)

1. 1. Comporti M. Glutathione depletign agents and lipid peroxidation. Chem Phys Lipids 1987; 45: 143-69.
2. 2. Takahachi K, Newburger PE, Cohen HJ. Glutathione peroxidase protein. Absence in selenium deficiency states and correlation with enzymatic activity. J Clin Invest 1986; 77: 1402-4.
3. 3. Meister A. New aspects of glutathione biochemistry and transport: Selective alteration of glutathione metabolism. Fed Proc 1984; 43: 3031-42.
4. 4. Mimic-Oka J, Djukanovic L, Markovic B. Erythrocyte and plasma glutathione levels in patients with chronic renal insufficiency. Biochem Med Met Biol 1988; 39: 48-54.
5. 5. Costagliola C, Libonti T, Menzione M, Kinaldi B, Auricchio G. Vitamin E and red blood cell glutathione. Metabolism 1985; 34: 712-4.
6. 6. Sieger CP, Younes M. Clinical significance of the glutathione-conjugation system. Pharm Res Commun 1983; 15: 1-13.
7. 7. Hirshman GH, Wolfson M, Mosimann JE, Clark CB, Dante ML, Wineman RJ. Complications of dialysis. Clin Nephrol 1981; 15: 66-74.
8. 8. Esehbach JW, Adamson JW. Anemia of end stage renal disease. Kidney Int 1985; 28: 1-5.
9. 9. Fisher JW, Lertora JJL, Lindhom DD, Tornyos K, Moriyama Y. Erythropoietin production and inhibitors in serum in the anemia of uremia. Proc Clin Dial Transplant Forum 1973; 3: 22-3.
10. 10. Moriyama Y, Rege AB, Fisher JW. Studies on an inhibitor of erythropoiesis. II. inhibitor effects of serum from uremic rabbits on heme synthesis in rabbit bone marrow cultures. Proc Soc Exp Biol Med 1975; 148: 94-7.
11. 11. Levinsky H, Galter U, Levi J, Allalouf D. Neuraminidase-like activitiy in sera of uremic anemic patients. Nephron 1984; 37: 35-8.
12. 12. Izumo H, Izumo S, DeLuise M, Flier JS. Erythrocyte Na, K pump in uremia. Acute correction of a transport defect by hemodialysis. J Clin Invest 1985; 74: 581-8.
13. 13. Durak I, Akyol Ö, Başeşme E, Canbolat O, Kavutçu M. Reduced erythrocyte defence mechanisms against free radical toxicity in patients with chronic renal failure. Nephron 1994; 66: 76-80.
14. 14. Fairbanks VF, Klee GG. Biochemical aspects of hematology. In Tietz NW, Ed. Textbook of Clinical Chemistry. Pp. 1508-10. WB Saunders Co., Philadelphia, 1986.
15. 15. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 1969; 27: 502-22.
16. 16. McCormick DB. Vitamins. In: Tietz NW, Ed. Texbook of Clinical Chemistry. Pp. 949. Philadelphia, WB Saunders Company, 1986.
17. 17. Pleban PA, Munyani A, Beachum J. Determination of selenium concentration and glutathione peroxidase activity in plasma and erythrocytes. Clin Chem 1982; 28: 311-6.
18. 18. Jacobson EB, Lockitch B. Direct determination of selenium in serum by graphite-furnace atomic absorption spectrometry with deuterium background correction and a reduced palladium modifier. Clin Chem 1988; 34: 709-714.
19. 19. Aggarwal SK, Saini AS. Formation and detoxification of oxygen free radicals and peroxides in erythrocytes. Int J Haematol 1984; 2: 39-44.
20. 20. Costagliola C, Romano I, Sorice P, Di Benedetto A. Anemia and chronic renal failure: The possible role of the oxidative state of glutathione. Nephron 1989; 52: 11-4.
21. 21. El-Rashidy FH, AI-Turk WA, Stohs SJ. Glutathione, glutathione reductase and glutathione S-transferase activities in erythrocytes and lymphocytes in chronic renal disease. Res Commun Chem Pathol Pharm 1984; 44: 423-9.
22. 22. Vanella A, Geremia E, Pintura R, et al. Superoxide dismutase activity and reduced glutathione content in erythrocytes of uremic patients on chronic dialysis. Acta Haemat 1983; 70: 312-5.
23. 23. Seth RK, Saini AS, Aggarwal SK. Glutathione peroxidase activity and reduced glutathione content in erythrocytes of patients, with chronic renal failure. Scand J Haematol 1985; 35: 201-4.
24. 24. Turi S, Nemeth H, Vargha H, Matkovies B, Dobos E. Erythrocyte defense mechanisms against free oxygen radicals in haemodialysed uraemic children. Pediatr Neph 1980; 5: 174-9.
25. 25. Sachs G, Siems W, Grune T, Schmidt G, Gerber G, Zoellner K. Nucleotide and glutathione status in erythrocytes of children undergoing chronic hemodialysis under erythropoietin treatment. Biomed Biochim Acta 1990; 49: 123-4.
26. 26. Brunetti P, Parma A, Neuci GG. Studi della anemie renali aumento della glutathione redutasi erithrocitaria negli stati iperazotemici. Hematologica 1965; 50: 415-46.
27. 27. Melissinos KG, Delidou AZ, Varsou AG, Begietti SS, Drivas GJ. Serum and erytrocyte glutathione reductase activity in chronic renal failure. Nephron 1981; 28: 76-9.
28. 28. Yawata Y, Howe R, Jacob HS. Abnormal red cell metabolism causing hemolysis in uremia. A defect potentiated by topwater hemodialysis. Ann Intern Med 1973; 79: 362-7.
29. 29. Rodriquez-Segade S, Ramos-Martinez JL, Freire M. Reversal effect of oxidized glutathione on the inhibition of glucose-6-phosphate dehydrogenase by NADPH. Biochem J 1985; 231: 805-6.
30. 30. Srivastava SK, Awasthy YL, Beutler E. Useful agents for the study of glutathione metabolism in erythrocytes. Biochem J 1974; 139: 289-95.
31. 31. Richard MJ, Arnaud J, Jurkovitz C, et al. Trace elements and lipid peroxidation abnormalities in pa tients with chronic renal failure. Nephron 1991; 57: 10-5.
32. 32. Paul JL, Sall ND, Soni T, et al. Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 1993; 61: 106-9.
33. 33. Saint-Georges MD, Bonnefont DJ, Baurely BA, et al. Correction of selenium deficiency in hemodialyzed patients. Kidney Int 1989; 36: Suppl 27: s274-7.
34. 34. Kostakopoulos A, Sofras JAF, Deliveliotis CH, Kallistratos G. Serum selenium levels in healthy adults and its changes in chronic renal failure. Int Urol Nephrol 1990; 22: 397-401.
35. 35. Dworkin BB, Weseley S, Rosenthal WS, Schwartz EM, Weiss L. Diminished blood selenium levels in renal failure patients on dialysis: Correlation with nutritional status. Am J Med Sci 1987; 293: 6-11.
36. 36. Foote JW, Hinks LJ, Lloyd B. Reduced plasma and white blood cell selenium levels in haemodialysis patients. Clin Chim Acta 1987; 164: 323-8.